James Loden, MD
Ophthalmology · Goodlettsville, TNNPI 1659330272
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $29,393 of the $39,873 with a category attached, or 73.7%. 24 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 58.5% of the total. Among ophthalmology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $206.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$23K
- Lensar, Inc.$9K
- Bausch & Lomb Americas Inc.$3K
- Omeros Corporation$2K
- Glaukos Corporation$750
- AbbVie$602
- plus $2K from 18 others
Across 48 payments — averaging $6032.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$164K
- Johnson & Johnson Surgical Vision, Inc.$108K
- Bausch & Lomb Americas Inc.$18K
What the payments were for
- Consulting fees$29,39374%
- Speaking & faculty fees$3,0268%
- Food & beverage$7,45419%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 46 | $23,327 |
| Lensar, Inc. | 20 | $8,972 |
| Bausch & Lomb Americas Inc. | 16 | $2,657 |
| Omeros Corporation | 10 | $1,616 |
| Glaukos Corporation | 17 | $750 |
| AbbVie(2 entities) | 28 | $602 |
| Biotissue Holdings Inc. | 14 | $482 |
| Alcon | 10 | $292 |
| NEW World Medical,inc. | 3 | $238 |
| Tarsus Pharmaceuticals, Inc. | 2 | $163 |
| Aerie Pharmaceuticals, Inc. | 2 | $125 |
| Carl Zeiss Meditec USA, Inc. | 2 | $122 |
| Carl Zeiss Meditec, Inc. | 3 | $119 |
| Sun Pharmaceutical Industries Inc. | 4 | $71 |
| Bausch Health US, LLC | 2 | $68 |
| Rxsight Inc | 2 | $56 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $44 |
| Shire North American Group Inc | 2 | $44 |
| Eyepoint US, Inc. | 3 | $42 |
| Ivantis, Inc | 1 | $22 |
| Ocular Therapeutix, Inc. | 1 | $19 |
| Sight Sciences, Inc. | 1 | $18 |
| Oyster Point Pharma, Inc. | 1 | $13 |
| Rayner Intraocular Lenses Limited | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Catalys Laser System$10,500
- COMPACT INTUITIV Phacofragmentation System$9,900
- LENSAR LASER SYSTEM$8,457
- iDesign Advanced Wavescan Studio$6,000
- INTRALASE FS FEMTOSEC LASER$5,400
- Healon Viscoelastics$5,100
- IDESIGN RS$3,600
- CLEARVISC$2,175
- CATALYS SYSTEM$1,800
- Compact Intuitiv$1,800
- Healon Duet Pro$1,800
- OMIDRIA$1,500
- WaveScan WaveFront System$600
- IntralAse FS Laser$600
- Tecnis 1-piece IOL$600
- Tecnis IOL$322
- iDoseTR$251
- Tecnis Simplicity$150
- VERITAS Vision System$137
- MIEBO$125
How this compares
$39,873 in reported general payments places this provider in the 90th percentile of 323 ophthalmology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 12 | $15,671 |
| RocklatanNetarsudil Mesylat/Latanoprost | 30 | $10,394 |
| LumiganBimatoprost | 11 | $5,682 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 19 | $3,703 |
| Bromfenac Sodium | 29 | $3,632 |
| Prednisolone Acetate | 20 | $755 |
| Latanoprost | 48 | $654 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 22 | $537 |
| MoxifloxacinMoxifloxacin Hcl | 13 | $407 |
| Timolol Maleate | 25 | $385 |
| Brimonidine Tartrate | 11 | $170 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 20 | $137 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $602 | $21,35323 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $125 | $10,39430 claims |
| AlconSimbrinza | $292 | $3,70319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 323 ophthalmology providers in Tennessee.
Other ophthalmology in Goodlettsville
- Katie MillsGoodlettsville$84K
- Amish PurohitGoodlettsville$35K
- Deborah ShermanNashville$3M
- Melissa ToyosMemphis$1.3M
- Rolando ToyosMemphis$809K
- Brian BiesmanNashville$630K
- Brian FowlerMemphis$206K
- Edward ChaumNashville$158K
- Brian JerkinsMemphis$150K
- James FreemanMemphis$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.